skip to Main Content

Newly Published Peer-Reviewed Study Shows Efficacy of Equashield CSTD in Preventing Hazardous Drug Contamination When Compounding Cytotoxic Medications in RealWorld Setting

PORT WASHINGTON, New York, Aug. 24, 2021 /PRNewswire/ -- Equashield (equashield.com), a leading provider of…

read more

The Time is Ripe for an Alternative to Automated Hazardous Drug Compounding

One area in which automation is not currently being utilized to its fullest potential is…

read more

The need for CSTD’s

read more

Lancement d’ Equashield® aux Pays-Bas

read more
Back To Top